Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs.
about
Cutting edge: Acute lung allograft rejection is independent of secondary lymphoid organs.Noninvasive tracking of donor cell homing by near-infrared fluorescence imaging shortly after bone marrow transplantationCurrent and future approaches for control of graft-versus-host disease.Depletion of host CCR7(+) dendritic cells prevented donor T cell tissue tropism in anti-CD3-conditioned recipients.In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host diseaseAltered T-cell entry and egress in the absence of Coronin 1A attenuates murine acute graft versus host disease.Tissue-specific homing and expansion of donor NK cells in allogeneic bone marrow transplantation.Separation of graft-versus-host disease from graft-versus-leukemia responses by targeting CC-chemokine receptor 7 on donor T cellsUp-Regulation of alpha4beta7 integrin on peripheral T cell subsets correlates with the development of acute intestinal graft-versus-host disease following allogeneic stem cell transplantation.Shift of graft-versus-host-disease target organ tropism by dietary vitamin A.Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.Langerhans cells are not required for graft-versus-host disease.CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells.CD8+CD44(hi) but not CD4+CD44(hi) memory T cells mediate potent graft antilymphoma activity without GVHDA diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model.Recipient B cells are not required for graft-versus-host disease induction.Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo.A repertoire-independent and cell-intrinsic defect in murine GVHD induction by effector memory T cells.Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.Organ-derived dendritic cells have differential effects on alloreactive T cells.Mapping immune processes in intact tissues at cellular resolution.Effects of donor T-cell trafficking and priming site on graft-versus-host disease induction by naive and memory phenotype CD4 T cells.Delta-like ligand 4 identifies a previously uncharacterized population of inflammatory dendritic cells that plays important roles in eliciting allogeneic T cell responses in mice.Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion.Homing in on acute graft vs. host disease: tissue-specific T regulatory and Th17 cells.Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of alloprimingSecondary lymphoid organs contribute to, but are not required for the induction of graft-versus-host responses following allogeneic bone marrow transplantation: a shifting paradigm for T cell allo-activationIn Vivo Cellular Imaging for Translational Medical Research.In vivo imaging of differences in early donor cell proliferation in graft-versus-host disease hosts with different pre-conditioning doses.Role of secondary lymphoid tissues in primary and memory T-cell responses to a transplanted organ.Role of beta7 integrins in intestinal lymphocyte homing and retention.New perspectives on the biology of acute GVHD.New ways to separate graft-versus-host disease and graft-versus-tumour effects after allogeneic haematopoietic stem cell transplantation.Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer.Insights into the pathogenesis of GvHD: what mice can teach us about man.DLL4+ dendritic cells: Key regulators of Notch Signaling in effector T cell responsesCCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect.T-cell expression of AhR inhibits the maintenance of pTreg cells in the gastrointestinal tract in acute GVHD.High incidence of extensive chronic graft-versus-host disease in patients with the REG3A rs7588571 non-GG genotype.
P2860
Q30543936-E7CCEB80-9284-48E1-BEC4-706647AAB912Q33608672-CE74CB3F-FB10-4B89-BF74-AC2BF993142DQ33642625-24F132F3-F198-4112-B54A-EE4057C0AEB5Q33756801-D3677B46-044C-4813-B6E2-339C63F0D23CQ33798249-C7BD2FA2-A93E-4705-86D9-2C5DFE3D0CFCQ33851696-97201F5B-D182-4DBC-B99B-70216D51435EQ33893091-1FC41E13-ECCE-4F28-8B90-5961BE3A972AQ33931876-252CAA19-F2A6-4587-9865-EDAA1013B179Q34156279-49557E97-1C7D-4858-8179-06982ABB53CFQ34292981-139AB40D-8386-4BE7-B9B6-4430BB8755BEQ34487408-D0187FCF-644F-4B18-AF19-8189FB9F74D7Q34542158-CE898644-6452-4968-8E82-1F8EF1AF1FDCQ34551230-BDDC64FA-DEE9-4A91-BE57-F2821AECE5F0Q34707286-CAF85C71-AFB6-422B-80D5-B3CD54D223E0Q34732865-D0D082A8-4F91-42B8-B54C-5DD8C99B5889Q35104223-E6DB9FAA-B0C1-4CE7-8ED6-5CC9FC301BDCQ35215430-712486FD-9F8D-41EF-B7F1-29F40CE59AFBQ35604083-7530C630-CC6D-4E0F-901B-A0375D33F1E6Q35662003-A2F31467-CFFD-49AA-9882-9C191EABF590Q36478458-08432787-5BF7-4BBE-94F6-45A92BB5D142Q36498101-270D999C-8206-4454-A9E0-B001E4F81613Q36658080-F4B671CD-E4C6-4D1E-9E11-AACA4809DE05Q36717891-9B17DF76-0D43-4C4B-B06C-120166A9470FQ37071152-5A0F8939-5F50-416C-AD46-FC7DFAF152A7Q37197925-08D1A121-8B65-40CA-B182-0ADCD688C244Q37223366-940A111F-064B-41A8-9D3D-E7F58A8A5D4FQ37268939-EFE6AAE1-C98C-4E0D-BC75-FA1F8FB63737Q37338471-6C313A86-87BF-49BD-B083-3C5F0C6084B2Q37352907-4E3F22C4-DAFD-40D0-8A14-8144E4A24F39Q37461682-EA149883-E8A9-4B73-A1E4-7E3EAB00BB69Q37619093-1CA7E33D-6082-49D9-932F-5D732EAFA010Q37622315-8DB428F6-765F-409E-9986-EDB17A96F22EQ37641063-581F3E27-8B1C-453C-98D4-B1D7D37C0889Q38057376-F425B90F-916B-4395-854A-B8C7FEEFEE71Q38198742-22B41464-2A9B-40D0-93E7-E68708CB9DECQ38297240-0C49E781-7E21-41FD-A02E-79BE164298EAQ38957582-CF843586-673E-4DEC-BF31-A9615D4DF4F8Q39027200-A6D68AB9-92FF-48EA-AC45-3CABD15C7515Q40183485-44D51529-94E2-4D5A-8615-8D92307085B2Q42130752-770BB128-5104-4F72-BE47-7B0D7AA47E4E
P2860
Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Prevention of acute graft-vers ...... to secondary lymphoid organs.
@ast
Prevention of acute graft-vers ...... to secondary lymphoid organs.
@en
type
label
Prevention of acute graft-vers ...... to secondary lymphoid organs.
@ast
Prevention of acute graft-vers ...... to secondary lymphoid organs.
@en
prefLabel
Prevention of acute graft-vers ...... to secondary lymphoid organs.
@ast
Prevention of acute graft-vers ...... to secondary lymphoid organs.
@en
P2093
P2860
P1433
P1476
Prevention of acute graft-vers ...... to secondary lymphoid organs.
@en
P2093
Andreas Beilhack
Edward I Herman
Enosh M Baker
Eugene C Butcher
Georg F Beilhack
Gilad Landan
Jeanette Baker
Robert S Negrin
Ryosei Nishimura
Stephan Schulz
P2860
P304
P356
10.1182/BLOOD-2007-09-112789
P407
P577
2007-11-07T00:00:00Z